Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain

NCT02143713 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02143713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02143713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Completed
Start date
May 27, 2014
Completion date
May 23, 2017
Enrollment
496 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis